[1]
C. Wang, “Correlative Factors of PD-1/PD-L1 Inhibitors-based Immunotherapy Responses in Non-small Cell Lung Cancer”, TMBLS, vol. 3, pp. 576–580, Mar. 2024, doi: 10.62051/mgznvq03.